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Background and Cellular Alterations Triggered in 
Diclofenac-Metabolizing Strain
Pseudomonas moorei KB4
Joanna Żur 1z* , Artur Piński 1@, Danuta Wojcieszynska 1, Wojciech Smułek 2© and 
Urszula Guzik 1z*
1. Introduction
Diclofenac (DCF), a phenylacetic acid derivative classified as a non-steroidal anti-inflammatory 
drug (NSAID), due to wide prevalence is considered as one of the most important contaminants of 
emerging concern. The presence of DCF in drinking [1-3], ground [4,5] or surface water [6,7], as well as 
sewage [8] and activated sludge [9,10] ranged from 0.02 ng L-1 to 20 gg L-1 [2]. The estimated annual 
worldwide consumption ofDCF is around 2400tons, which is partly conditioned byits over-the-counter 
access [3]. In recent years, the usefulness of traditional physico-chemical sewage treatment methods 
applied to the removal of recalcitrant pollutants is being increasingly questioned [2]. Despite that
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Abstract: Diclofenac (DCF) constitutes one of the most significant ecopollutants detected in various 
environmental matrices. Biological clean-up technologies that rely on xenobiotics-degrading 
microorganisms are considered as a valuable alternative for chemical oxidation methods. Up to 
now, the knowledge about DCF multi-level influence on bacterial cells is fragmentary. In this 
study, we evaluate the degradation potential and impact of DCF on Pseudomonas moorei KB4 strain. 
In mono-substrate culture KB4 metabolized 0.5 mg L-1 of DCF, but supplementation with glucose 
(Glc) and sodium acetate (SA) increased degraded doses up to 1 mg L-1 within 12 days. For all 
established conditions, 4'-OH-DCF and DCF-lactam were identified. Gene expression analysis 
revealed the up-regulation of selected genes encoding biotransformation enzymes in the presence of 
DCF, in both mono-substrate and co-metabolic conditions. The multifactorial analysis of KB4 cell 
exposure to DCF showed a decrease in the zeta-potential with a simultaneous increase in the cell wall 
hydrophobicity. Magnified membrane permeability was coupled with the significant increase in the 
branched (19:0 anteiso) and cyclopropane (17:0 cyclo) fatty acid accompanied with reduced amounts 
of unsaturated ones. DCF injures the cells which is expressed by raised activities of acid and alkaline 
phosphatases as well as formation of lipids peroxidation products (LPX). The elevated activity of 
superoxide dismutase (SOD) and catalase (CAT) testified that DCF induced oxidative stress.
Keywords: biotransformation enzymes; cells injury; diclofenac; gene expression; membranes; 
metabolites; oxidative stress; Pseudomonas; toxicity 
www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2020, 21, 6786 2 of 22
removal efficiency of DCF by advanced oxidation processes reaches up to 80%, the limitations of these 
methods frequently preclude their use [10-12]. DCF as a hydrophobic chlorinated derivative with 
electron-withdrawing and donating groups has a log D < 3.2 at pH 8.0, which hinders the biological 
removal [13,14]. Bioremediation is an eco-safe and economically justified alternative for harsh chemical 
treatments being based on the individual microbial strain able to detoxify the particular compound or 
microbial consortia with more complex metabolic properties. Bacteria from the genus Pseudomonas are 
widely known as able to reside in hostile environments since they constitute the indigenous microflora 
of various contaminated areas i.e., soil, sludge, water bodies and wastewater. The ecological success 
of pseudomonads can be attributed to great metabolic versatility, effective detoxifying and adapting 
mechanisms based on the high oxidoreductase activities, adjusting the membranes fluidity or extensive 
transport, and secretion systems [15].
To date, a few reports about complete DCF degradation have been published (Table S1). 
Moreira et al. [10] described Labrys portucalensis F11 strain able to degrade DCF under the co-metabolic 
conditions with sodium acetate. Ivshina et al. [2] isolated Rhodococcus ruber IEGM 346 strain 
able to degrade 50 pg L-1 of DCF during 6 days. The bacterial DCF degradation has also been 
demonstrated for Enterobacter hormachei D15 [16],Raoultella sp. DD4[17], Brevibacterium sp. D4 [18] 
and Klebsiella sp. KSC [19]. More recently, Palyzova et al. [20] with the use of chemical mutagenesis 
obtained a Raoultella sp. KDF8 strain that is capable of converting DCF to primary metabolic products. 
Nguyen et al. [2 1] reported about the potential of bacteria from genera: Nitratireductor, Asticcacaulis and 
Pseudoxanthomonas to metabolize DCF under co-metabolic conditions. Finally, Grandclement et al. [14] 
described Bacillus subtilis and Brevibacillus laterosporus that metabolized 1 mg L-1 of DCF in a nutrient 
broth medium during 17 h. Navrozidou et al. [22] described the main microbiota involved in 
DCF-degradation in the activated sludge fed with DCF as a sole carbon and energy source. The major 
bacterial taxa identified in the immobilized cell biofilter were Granulicella pectinivorans and Rhodanobacter 
terrae as well as the members of the species Castellaniella denitrificans, Parvibaculum lavamentivorans, 
Bordetella petrii, Bryocella elongata and Rhodopseudomonas palustris. We have previously described two 
novel strains isolated from DCF-treated activated sludge from Serratia and Rahnella genera [23]. So far, 
degradation of DCF has not been confirmed for any strain of Pseudomonas genus. Despite the relatively 
large body of the literature about DCF degradation, mainly by activated sludge microflora [18,23-26], 
the genetic background of its decomposition remains scarce. Palyzova et al. [20] reported about the 
presence of few genes related to DCF degradation encoding catechol 1,2-dioxygenase, protocatechuate 
3,4-dioxygenase and quercetin 2,3-dioxygenase in Raoultella sp. KDF8 strain genome. The genetic 
analysis coupled with shot-gun proteomics revealed the up-regulation of 24 intracellular proteins 
engaged in the metabolic pathways of degradation of benzoate, catechol and genes associated with 
oxidoreductases in response to DCF treatment.
The native microflora play an important role in the biological detoxification of contaminants 
acting as a primary response triggering the modifying reactions. Considering the literature data, 
there is a limited understanding of DCF exposure effects on prokaryotic organisms, thus broadening 
of knowledge about protective mechanisms and the influence of xenobiotics on bacteria is still 
necessary [2]. The impact of DCF on the physiological status of the cell is mostly multidirectional and 
concerns different cellular and sub-cellular levels i.e., oxidative stress, lipids peroxidation, alterations 
in receptor activity, destruction of the membrane-associated proteins or membranes permeability 
modification [27,28]. The two most frequently detected DCF hydroxylated derivatives: 4'-OH-DCF 
and 5-OH-DCF, can be further oxidized to reactive benzoquinone imines that interplay with the protein 
nucleophilic groups, which results in adducts formation [2,27,29]. Physico-chemical properties of 
DCF molecule, mainly the n-octanol/water partition coefficient (log Kow, 4.51), are responsible for 
potential bioaccumulation in the living organisms, mainly aquatic microbiota. The ecotoxicological 
effects of DCF even at concentration levels as low as 1 pg L-1 have been reported for different groups 
of organisms, e.g., Daphnia magna where exposure resulted in the multiplied formation of reactive 
oxygen species (ROS), decreased filtration and ingestion rates, leading to behavioral and biochemical 
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alterations [3,14]. The high toxicity of DCF at environmentally relevant concentrations on duckweed 
Lemna minor was reported by Kummerova et al. [30]. Fu et al. [31] investigated the interplay between 
bioaccumulation and biotransformation processes of DCF in the model invertebrates Gammarus pulex 
and Hyalella azteca. The recently described DCF by-product, DCF-methyl ester was characterized 
by a significantly higher bioconcentration factor, namely 25- and 110-fold for G. pulex and H. azteca, 
respectively. The LC50 of DCF for H. azteca was amounted at 216 mg L-1, while that of methyl ester 
was reduced to 0.53 mg L-1, indicating a 430-fold increase in acute toxicity compared to DCF [31]. The 
most known example of toxicity of DCF residues is the decline of the population of oriental black-white 
vultures in India and Pakistan due to renal failure [32].
Considering the gaps of knowledge in the aspect of DCF bacterial degradation, this study aimed 
to (i) analyzing the catabolic potential of Pseudomonas moorei KB4 to DCF degrade under different 
nutritional conditions and secondary metabolites formation, (ii) measuring DCF degradation-related 
relative gene expression and (iii) estimating the multidirectional influence of DCF on the bacterial 
cells and oxidative stress level triggered by DCF. Despite the literature data about DCF influence 
on the bacterial cells, holistic studies about its interplay with DCF-degrading strains including gene 
expression analysis, degradative enzymes and a battery of physiological assays are scarce.
2. Results
2.1. Degradation and Metabolites Formation of DCF under Monosubstrate and Co-Metabolic Conditions
To test a catabolic potential of the KB4 strain to DCF degradation, different nutritional conditions 
were established. Based on the obtained results, the KB4 strain was characterized by different catabolic 
capabilities dependent on the conditions which were applied (Figure 1a). In the mono-substrate 
experiment, the degraded dose of DCF amounted to 0.51 ± 0.01 mg L-1 (51%) for 12 days. 
Under co-metabolic conditions with Glc supplementation, the degradation was most effective and 
reached 1 mg L-1 (100%) within 11 days. The similar efficiency of DCF degradation amounted to 
1 mg L-1 (100%) was achieved by the addition of two additional carbon sources, namely Glc and 
SA. However, degradation time for this system was extended by one day, compared to co-metabolic 
culture with Glc. The lack of significant changes in the concentration of DCF within 12 days in the 
abiotic control without bacteria confirmed no chemical oxidation of DCF. The average degradation 
rate was 0.045 ± 0.00, 0.142 ± 0.00 and 0.125 ± 0.00 mg L-1 day-1 for mono-substrate, supplemented 
with Glc and supplemented with Glc and SA cultures, respectively. For all established cultures 
target analysis using UHPLC/MS/MS and/or GC-TOFMS of secondary metabolites formation was 
performed (Figure S1). Based on the literature data about the most frequently occurring microbial 
DCF by-products, we confirmed the formation of 4'-hydroxylated DCF (4'-OH-DCF) and generated 
during intramolecular ring closure DCF-lactam in both mono-substrate and co-metabolic cultures 
(Figure S1). Additionally, for co-metabolic culture with Glc, the degradation product with m/z at 41, 
55, 75, 149 and 207 corresponding to phthalate acid was found. The measurements of degradation 
were coupled with cell growth and pH estimation (Figure 1b). Despite the observed degradation of 
DCF in mono-substrate culture, the increase in the number of cells for this system was not observed, 
which indicated that the KB4 is not able to proliferate in the presence of DCF as a sole carbon and 
energy source., The most significant cell proliferation has been observed for co-metabolic conditions 
with Glc and for Glc and SA. In the control experiment with Glc cell growth was substantially higher, 
which suggested high toxicity of DCF. The pH measurements indicated that Glc assimilation lowered 
pH value. For the control, the initial pH dropped from the initial 7.20 ± 0.00 to the final 6.25 ± 0.06. 
Over the experiment, pH of the culture in the mono-substrate system ranged from the initial 7.20 ± 0.00 
to 7.05 ± 0.01 at the end of the experiment and starting from 7.20 ± 0.00 to 6.24 ± 0.08 at the end for the 
co-metabolic conditions with Glc, and from 7.40 ± 0.00 to 7.08 ± 0.08 for Glc and SA.
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In order to reveal the enzymology of microbial degradation of DCF, the specific activity of selected 
enzymes from different groups was measured (Table 1). For enzymes with identified corresponding 
genes in the KB4 genome, the relative expression levels were determined (Figure 2). Thus, the specific 
activity of 16 enzymes and the expression of 13 genes for control, mono-substrate and co-metabolic 
cultures was measured. The expression level of two considered aromatic-ring-hydroxylating 
dioxygenases (EKG40_03810 and EKG40_04010) increased in DCF treatment in mono-substrate culture. 
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in which expression was increased 80-times compared to the control treatment. In the co-metabolic 
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gene expression was 65-fold higher than the control treatment with Glc. For co-metabolic culture 
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treatment. The third analyzed gene (EKG40_20055) was characterized by the highest activity observed 
in the co-metabolic conditions.
The measurements of the specific activity of dixydroxylating dioxygenase showed a similar trend 
with the highest activity observed for mono-substrate culture. The expression level of two analyzed 
catechol 1,2-dioxygenases, EKG40_03995 and EKG40_08570, significantly increased after DCF exposure, 
48 and 145-times, respectively. In the presence of Glc and DCF, the up-regulation was less pronounced 
and amounted to 19-fold for EKG40_03995 and 22-fold for EKG40_08570. The expression of the third 
catechol 1,2-dioxygenase (EKG40_25940) showed up-regulation after DCF treatment but leveled-off for 
both conditions. The expression level of the intradiol ring-cleavage dioxygenase (EKG40_24095) was 
almost 11.5-fold higher in the presence of DCF. The highest up-regulation (almost 90-fold) was measured 
for the co-metabolic conditions with DCF and Glc. The expression of deaminase (EKG40_15900) 
was significantly up-regulated in the presence of DCF. A quite similar level was observed in the 
control with Glc, and co-metabolic culture with Glc and DCF. The highest activity of deaminase 
in the mono-substrate culture with DCF was observed. The expression of second gene encoding 
deaminase (EKG40_15900) was down-regulated in both treatments with the highest drop observed 
in co-metabolic conditions. The expression of benzoate 1,2-dioxygenase (EKG40_08550) was almost 
3-times higher for mono-substrate culture than the value measured for control with Glc. The significant 
up-regulation (above 8.5-times) of this gene was observed in co-metabolic culture. The expression of 
homogentisate 1,2-dioxygenase (EKG40_02865) in the culture with Glc and DCF was almost 20-fold 
and 5-fold higher than expression measured for the control with Glc and mono-substrate culture with 
DCF, respectively. Similar results were obtained from the enzymatic measurements, were the highest 
activity of homogentisate 1,2-dioxygenase was observed in co-metabolic culture. The expression of 
the gene that encodes cytochrome P-450 (EKG40_27950) increased 4-fold in co-metabolic conditions. 
For the mono-substrate culture, the expression was almost twice lower than the control. For the 
other enzymes, in the case of the aromatic monooxygenase measured with phenol as a substrate 
the highest specific activity was observed for co-metabolic culture. Similarly, the highest activity 
of protocatechuate 3,4-dioxygenase and salicylate 1,2-dioxygenase was observed in co-metabolic 
culture. The opposite trend, with the highest activity in mono-substrate culture, was observed for 
hydroquinone 1,2-dioxygenase, quercetin 2,3-dioxygenase and laccase. No activity was detected for 
gentisate 1,2-dioxygenase and protocatechuate 4,5-dioxygenase. Two enzymes were active only in the 
control with Glc, namely, catechol 2,3-dioxygenase and hydroxyquinol 1,2-dioxygenase.
Table 1. The specific activity of selected enzymes (U mg-1 of protein) measured for control with Glc, 
mono-substrate conditions with DCF and co-metabolic conditions with Glc and DCF.
Enzyme Glc DCF Glc + DCF
Aromatic monooxygenase 3.065 ± 0.001 a 11.660 ± 0.006 b 110.115 ± 0.07 c
Dihydroxylating dioxygenase - naphthalene 0.000 ± 0.000 a 12.012 ± 0.001 b 6.940 ± 0.043 c
Salicylate 1,2-dioxygenase 0.000 ± 0.000 a 0.207 ± 0.071 b 0.302 ± 0.021 c
Gentisate 1,2-dioxygenase 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000
Homogentisate 1,2-dioxygenase 0.000 ± 0.000 a 1.034 ± 0.002 b 3.006 ± 0.004 c
Catechol 1,2-dioxygenase 1.000 ± 0.010 a 2.062 ± 0.051 b 1.731 ± 0.035 c
Catechol 2,3-dioxygenase 1.850 ± 0.094 a 0.000 ± 0.000 b 0.000 ± 0.000 b
Protocatechuate 4,5-dioxygenase 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000
Protocatechuate 3,4-dioxygenase 55.123 ± 0.010 a 12.249 ± 0.010 b 66.695 ± 0.189 c
Hydroquinone 1,2 dioxygenase 0.000 ± 0.000 a 0.004 ± 0.000 b 0.000 ± 0.000 a
Hydroxyquinol 1,2-dioxygenase 0.932 ± 0.046 a 0.108 ± 0.025 b 0.000 ± 0.000 c
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Table 1. Cont.
Enzyme Glc DCF Glc + DCF
Benzoate 1,2-dioxygenase 0.000 ± 0.000 a 1.395 ± 0.000 b 3.033 ± 0.000 c
Quercetin 2,3-dioxygenase 0.000 ± 0.000 a 0.023 ± 0.001 a 0.000 ± 0.000 a
Peroxidase 0.017 ± 0.002 a 0.004 ± 0.001 b 0.004 ± 0.002 b
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The KB4 cells cultivated on MSM are characterized by relatively low hydrophobicity (22.54 ± 2.01%) 
as we described previously [33]. After DCF treatment, the hydrophilicity of the KB4 strain cell wall 
significantly declined (p < 0.01) and the cell wall became more hydrophobic reaching up to 63.94 ± 2.43% 
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(one-way ANOVA ffoolllooweeddbbyytthheelleeaassttssigignniififcicaannttddiffifefererenncceess(L(LSSDD) )teteststwwitihthaapp-v-vaaluluee<<00.0.011))..
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2.4. The Inflfluence of DCF on Fatty Acids Composition and Membrane Permeability
As membrane lipids are one of tthe mostt aadapttablle molleculles,, alltterations in ttheiir composition 
and amount can be a valuable marker of the toxic eff fects of DCF on bacterial cells. IIn thiis study, 
identifified ffattttyaaccididsswwereer edidvivdieddedintiontowtowgorogurposu: pusn:sautnusratuedraatned saantdursaatetudr. aTtheed.latTtehrewlatstfeurrwthaesr 
fduirvtihderddiinvtiodehdydinrotoxyhly, dstrroaxigyhl,t-sctrhaiignhat-ncdhabirnananchdebdraoncehs.eAd noanleys.isAonfatlhyesiosbotfaitnhedopbtraoifnileds sphrowfileds 
showed relevant changes in the content of unsaturated, 16:1cc6c/16:1cc7c and 18:1c86c/18:1cc7c acid, 
and cyclopropane fatty acids Wetween control samples with Glc and after DCF treatment for all selected 
times of incubation (Figure 4). The statistically significant changes were also observed in the amount 
of branched fatty acids,  19::0 aantteeiissoolanndd1199:0:0isisoo, ,bbeetwtweeennccoonntrtorol llannddDDCCF-Ft-rterletaetdedslsmamplpelseslfateftre1r616h 
hl nadn2d42h4 ohf ionfcuinbclutiboant.ioAnn.llAfsniasloyfsitsheocfotnhteencot no ftesntrtloigfhstt-rcahi lgihnt-lcnhdaihnf adnrodxfhlyldterdoxfylltatfteldcifdasttsyhoawcideds 
snhooswigendinfioclsnigt ncihfilcnagnet schbaentwgesebnectewllesenexcpeollseedxpt osGeldctlonGdlcDaCnFd. DACmFo. nAgmcofncglocpyrcolopplrnoepfalntteffatctiydas,citdhse, 
thhieg heigsthceostncteontteonft1o7f:017cy:0clcoywclolswoabssoebrvserdveldftearfttehrethsheosrhteosrteesxtpeoxspuorseutriemteimoef o16f 1h6. hT.hTe hperepsrensceencoef 
o1f9:109:c0y clyoclo 8cc8wc wlsaschclhrarcatcetreizriezdedonolnflyfofor rDDCCFF-t-rterelateteddsslamppleless. . TThheelleevveell of hydroxylated acid 
content, mainly 10:0 3OH and 12::0 3OH,, was rralttherr cconssttantt alnd nnoott eexxcceeeedss33.5.5%.. The priincipal 
component analysis (PCA) (Figure 4) suggested that fatty acid methyl esters (FAMEs) extracted from 
DCF-treated samples after 24 h were distinct in comparison with the other fatty acids along with the 
factor 1 (52.25%) and were mainly characterized by diverse content of 12:0 2OH, 18:0, 14:0, 17:0 cyclo 
and 19:0 anteiso acids. The analysis of the fatty acids composition was coupled with the membrane's 
permeabiilliitty measurreemeenttss.. A similar trend was observed for all DCF treatments and control culture 
with Glc (Fiigure 5).. In the control samples, the lowest CV uptake which indicated low permeability 
of 48.03 ±00..2255% wlassnnootitciceeddininsisxixththd dl fayo fotfhtehexepxepreimrime netn(t6()t.6A).t Athtethstelrstaorfttohfetehxepexrpimereinmt e(tn1t),(th1)e, 
tpheermpeerlmbeilaitbfiliwtylws salsigshlitglhf thlyighhige hr elrnadnldmamouonutnetdedtoto525.20.606±±4.45.5%5%. .OOnnththe elllasst tddlafy off the experiment 
(t12), the permeability was signif iicantly altered and estimated at 16..64 ± 2.96%. Over the experiment, 
the lowest permeability was observed for mono-substrate culture with DCF. At the beginning of 
treattmentt ((tt11), the permeabiliity reached 400..2233± 2.48% with a slight increase tto 49..29 ± 0.33% observed
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at t6. The final value in the 12 day dropped from 27.60 ± 5.03 to 21.25 ± 0.66%. For co-metabolic culture 
with Glc and DCF, the similar observations concerned the changes in the permeability were made. 
The lowest CV uptake was reported at t6 (55.20 ± 0.26%), with quite a similar level of 48.65 ± 3.06% at 
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FiguFrigeu4r.e (a4.) P(ae)rcPeenrcteangteagoef tooftatol tfalttfyatatycidacsidfosrfcoornctoronltraonl dancdellcselalfstearftDerCDFCeFxpeoxspuorseuraet taht ethceoncentration 
of 1comncgenLtr-a1tioanftoefr1dmiffgeLr-e1 naftteirndciuffberaetniot ninctuimbaetiso.n tTimhes.dTahtea daartea aprreepsreensetnedtedaasstthe meeaannvavluaelsues of three 
biolofgtihcraele rbeioploligciacatel sre; p(lbic)atpesr;in(bc)iprailn ciopmal pcoomnpeonntenatnaanlaylsyissis((PCA))oof faftatyttayciadcriadtioraintitoheincotnhtreolcontrol and 
cultcuornetsrowl ainthd tDhCeFa-tdredaitteidoncelolsf aDftCerFd; i(fcfe)rtehnet ipncruobjeactitoinontimofesfaotntythaecpidlasnepdroeffiinleeds ibsyolFaatcetodr f1roanmd the control 
andFDacCtoFr-2t.r eaa,bt,ecd—sctealtlistiacfatlelyr sdigiffneifriceanntt idnicffuerbeantcieosnutsimngeas one-twheaypAlaNnOeVdAefiwniethdabpy-vFaaluceto<r 01.0a5nd Factor 2. 
a,b,cfo—lloswtaetdisbtiyclaelalsyt signnifiificacnatndtidffieffreenrceensc(eLsSDu)stiensgt. a one-way ANOVA with a p-value < 0.05 followed by 
least significant differences (LSD) test.
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Figure 5.. ChCahnagnegs eisn imnembemrabnreapnermperambieliatbyilmityeasmuereadsubreydCbVyuCptVakue.pCtaVke—. cryCsVta—l cvrioylsetta,l DvCioFl—et, 
dDiCclFo—fendaicl,oGfelcn—acg, luGcloc—se.gTluhceosdea.taTahre pdraetsaenatreedparsesthenetmedeaans vthaleuemseoafnthvraeleuebsioolofgtihcarel erebpiloicloagteisca±l 
sretapnlidcatredsd±esvtiantidoanr.dad,be,vc—iatsitoant.isat,ibca,cl—ly stiagtnisitficalnlyt dsigffneirfiecnacnetsduisffienrgenacoenseu-swinagyaAoNnOe-VwAaywAitNhOaVpA-vwaliuthe 
<a p0-.v0a5lufeol<lo0w.0e5dfobllyowleeadstbysilgenasiftisciagnnti fidciaffnetrdeniffcersen(LceSsD(L) StDes)ttefostrfodrifdfeiffrenretntitmimese;s; A,,B,,C—ssttattiisttiically 
signiffiicant difffferences using a one-way ANOVA with a p-vallue < 0.05 followed by least signif iicant 
dif fferences (LSD) test for diff ferentt ttrreeaattmeenttss..
2 . 5 .  O x iid aattiiv e  S ttrre s s  a n d  C e l lls  I n j u r y  I n d u c e d  b y  D C F
The level of oxidative stress induced by DCF treatment was measured by catalase (CAT) and 
superoxide dismutase (SOD) activity. The CAT activity in DCF treatment for mono-substrate and 
mcoe-tmabeotalibcocloicncdoitniodnitsioinncsreinacsreedacsoedmpcoamrinpgartointghetocotnhteroclowntirtohlGwlcit(hTaGbllce (2T)a. bStleat2s)t.icSatlalytilsotiwcaelrlyacltoivwiteyr 
activity compared to co-metabolic culture was measured for mono-substrate conditions. The lowest 
SOD activity was measured for the control sample with Glc. Slightly higher activity was observed for 
Glc + DCF, whereas for mono-substrate culture, the SOD activity raised almost 6.5-fold. The cell's injury 
was estimated by measuring the activity of phosphatases with different pH optimum. The up-regulation 
roefgtuhleaaticotniviotfy tohfeaalkcatilviniteypohfoaslpkhaalitneecopmhopsaprehdatteoctohme cpoanrterdoltowitthheGcolcnwtraosl owbistherGveldc wfoarsalolbessetravbelidshfeodr 
cultures with the highest value observed for the mono-substrate conditions. For acid phosphatase, 
under mono-substrate conditions, the activity was lower than the basal activity in the presence of 
Glc. The slight increase was observed for co-metabolic culture with the highest activity of 0.34 ± 0.02 
Bessey's units. LPX induced by the presence of DCF was observed for both mono-substrate and 
co-metabolic cultures, with the highest malondialdehyde (MDA) concentration observed in DCF and 
Glc culture.
Table 2. The specific activity of CAT (U mg-1 of protein), SOD (inhibition rate, %), LPX (MDA, 
Tnmabollem2.gT-h1 eofsperocitfeiicna),ctailvkiatylinoef aCnAdTa(cUidmphgo-1sopfhpatraostesin()B, eSsOseDy'(sinuhniibtsit)i.on rate, %), LPX (MDA, nmol
Enzyme/Parameter Glc DCF Glc + DCF
ECnAzTymeC/ApaTramete0r.30 ± 0.11Ga lc a 11.0.044±D±0C0.0F.606b b Glc 2+.3D4C±F0c.57 c
SOD SOD 10.51 ±100..501  a± 0.01 a 8800.3.31 1±±0.00.0 0b b 12.5912±.509. 0±30c.03 c
alkalinaelpkhaolisnpehapthasoesph
acid phaocsipdhapthasoespha
ata0s.e02 ± 0..021 a± 0.01
ase0.17 ±00..1071 a± 0.01
a 22.1.100±±00.0.303b b
a 00.0.044±±00.0.0 0b b
2.07 ± 0.03 b
0.34 ± 0.02c
LPX LPX 0.00 ± 0..00 a± 0.00 8.67x10-6b 9.87 x 10-8 c
CAT—ccaatatlaalsaes,e,SODSO—Dsu—pesruopxeidreoxdidisemutdaissem, uLPtaXs—e,lipLidPXpe—rolxipididationpeprrooxdiudcattsi,onMDpAr—odmuaclotsn,diaMldDehAyd—e, 
Glc—glucose, DCF—diclofenac, SA—sodium acetate. a,b,c—statistically significant differences using one-way 
mANalOoVnAdiwalidtheahyp-dvea,lueG<l0c.—05gfloullcoowsed, byDtCheFl—eadsticsilgonfeifincacn,t diSffAer—enscoesd(iLuSmD) teasct.etate. a,b,c—statistically
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3. Discussion
Due to the increasing concerns about environmental pollution, in recent years the broadening 
of knowledge about the multi-level influence of xenobiotics on bacterial strains used in clean-up 
technologies is observed and realized in a growing number of isolated strains able to DCF metabolize [14]. 
Up to now, several DCF-degrading strains belonging to different genera including Gram-negative 
Klebsiella sp., Pseudoxanthomonas sp., Raoultella sp. or Serratia sp., as well as Gram-positive Bacillus sp., 
Brevibacillus sp., Enterococcus sp. or Rhodococcus sp., have been described. In this study, we aimed to 
estimate a catabolic potential of P. moorei KB4 strain, partly conditioned by its high tolerance (EC50 above 
5.0 g L-1) towards DCF under different metabolic conditions. The achieved degraded doses ranged 
between 0.5-1.0 mg L-1 for both, mono-substrate and co-metabolic cultures supplemented with Glc and 
Glc + SA, far exceeds the environmentally relevant concentrations of DCF and its metabolites. However, 
the time required for degradation indicated high chemical stability of the DCF molecule [2]. For most 
DCF-degrading isolates, co-metabolic conditions with various additional carbon sources i.e., Glc, SA or 
glycerol, have been applied. It is widely known that supplementation with an external source of carbon 
and energy may ensure bacterial growth and, subsequently, the better degradation capabilities [34]. 
For the KB4 strain, the addition of Glc and SA generally allow to intensified DCF degradation from 51% 
to 100% ofthe administered dose. Similar observations were made by Ivshina et al. [2], who showed the 
intensification of DCF degradation in the presence of Glc and Moreira et al. [10], who achieved higher 
degraded doses of DCF by periodic supplementation of the culture with SA. However, the presence 
of easily accessible carbon source, which serves as an electron-donating compound, may have also 
the opposite effect as demonstrated by Larcher et al. [35] and Aissaoui et al. [16]. A similar degraded 
dose was shown by Grandclement et al. [14] for B. subtilis and B. laterosporus, which metabolized 
1 mg L-1 of DCF in a nutrient broth medium during 17 h. In our previous work, we have isolated 
from DCF-treated activated sludge S. proteamaculans AS4 and R. bruchi AS7 strains, that were able to 
degrade nearly 0.5 mg L-1 of DCF within 14 days after 1.0 g L-1 of Glc addition [23]. Moreira et al. [10] 
described complete degradation of DCF via co-metabolism at the concentration of 1.7 pM during 
6 days and 34 pM during 25 days by L. portucalensis F11 strain. Aissaoui et al. [16] achieved 52.8% 
elimination of DCF at the concentration of 10 mg L-1. After Glc addition, degraded dose increased up 
to approximately 82%. The significantly higher degradation rate was shown by Palyzova et al. [36] for 
Raoultella sp . KDF8 strain after chemical mutagenesis which metabolized nearly 1.0 g L-1 of DCF. A lack 
ofsignificant(2-5%)physico-chemical DCFdecompositionobserved within this study, whichconfirmed 
the biological nature of DCF degradation, was also showed by Ivshina et al. [2]. During the experiment, 
the cell growth measurements were performed. For mono-substrate culture, the decrease in the 
bacterial biomass was observed, which indicates that DCF at the applied concentration was insufficient 
as the sole carbon and energy source. For the control experiment with Glc, the observed number 
of cells was significantly higher than those measured for co-metabolic cultures which may indicate 
DCF toxicity. Interestingly, for culture with two external carbon sources, Glc and SA, the growth was 
significantly lower in the period of 2 to 9 days in comparison with culture with DCF and Glc. Moreover, 
no significant reduction in degradation rate was observed in the presence of SA. In addition, after 10 
days of culture, the growth inboth co-metabolic systems was comparable. This mayindicate differences 
in DCF metabolism by the tested strain in the presence of SA. To complete the overall picture of DCF 
degradation, the pH measurements of cultures were also performed. A similar trend was observed for 
all established cultures, but with a varied dynamic. It is widely known that Glc assimilation lowers 
the pH, mainly due to acetoin and organic acids formation [36,37], thus, the strongest decrease in 
the pH was observed for control with Glc. In the mono-substrate culture, the pH slightly decreases 
to almost neutral (7.05 ± 0.01). Noteworthy, DCF was applied as a sodium salt which additionally 
may alter the pH of the culture. Pobudkowska and Domańska [38] indicated that the pKa of DCF 
sodium ranges between 4 and 5.7. This indicates its dissociation under culture conditions, which leads 
to slight alkalization of the environment. At the same time, during DCF degradation, the formation 
of phthalic acid was observed. The influence of these two phenomena may explain the pH value 
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observed at the end of the culture. Among co-metabolic cultures, the greater decline was observed for 
Glc + DCF system which may indicate that for the system with DCF + Glc + SA, SA alleviated the pH 
value. The alkaline or almost neutral pH may also be a result of by-products formation, mainly amines 
e.g., 4-aminophenol or 4-amino-3,5-dichlorophenol formed e.g., via amidation or amide hydrolysis, 
thus alkalizing the culture [2,26]. On the other hand, Palyzova et al. [36] demonstrated that after 
96 h of degradation, the pH of the culture with basal salts broth medium supplemented with DCF 
dissolved in ethanol and incubated at 28 ◦ C ranged from 3.4 to 4.6. Low pH of the cultures may also 
be associated with the formation of carbonic acid. The literature data regarding the optimal pH for 
DCF degradation are inconsistent. According to Vieno and Sillanpaa [9], the acidic pH enhanced DCF 
removal, nevertheless, Palyzova et al. [36] for Raoultella sp. KDF8 strain demonstrated that in the initial 
pH below 7, DCF degradation is impeded, and most of its dose remained undissolved, thus, authors 
pointed out that the optimal pH for DCF removal varied from 7 to 9.
The reactions occurring during DCF degradation are mostly multidirectional [10,25,26]. The major 
advance of our results to previous reports where several identified metabolites and proposition of the 
putative DCF pathway were given, rely on the measurements of the specific activity of degradative 
enzymes and integration of these data with relative expression level of genes encoding those enzymes. 
Most recently, Ivshina etal. [2] proposed three putative DCF degradation pathways with 16 identified 
metabolites on the example of R. ruber IEGM 346 strain. The hydroxylation of DCF molecules 
to 4'-OH-DCF, which is considered as a bottleneck metabolite during DCF biodegradation, up to 
now was confirmed also for Actinoplanes sp. [39], Raoultella sp. KDF8 [36] and L. portucalensis F11 
strains [10]. The target analysis performed within this study for the KB4 strain confirmed the formation 
of 4-OH-DCF in all established cultures, which indicated that the initial steps of DCF biodegradation 
proceed via hydroxylation and seem to be common for both mono-substrate and co-metabolic 
conditions. Noteworthy, 4-OH-DCF formation is also observed during human metabolism of DCF by 
the activity of cytochrome P-450, which was also shown for bacteria [14]. The high expression of gene 
encoding cytochrome P-450 during DCF degradation by the KB4 strain confirmed its involvement 
in DCF metabolism. The second identified metabolite whose formation was proved for all cultures 
—DCF-lactam—was also found during DCF degradation by E. hormaechei D15 and the microbial 
consortia in the activated sludge [26]. Interestingly, in all studies regarding DCF degradation, several 
additional metabolites with defined m/z spectra have been found, however some were unidentified and 
their chemical structures were unresolved [9,40]. Further degradation of hydroxylated derivatives may 
proceed via different pathways, which is indirectly proven by the activity of dioxygenases cleaving the 
aromatic ring differently. As a result of hydroxylation, four key metabolites may be formed: catechol, 
protocatechuic acid, hydroxyquinol, and gentisic acid [41]. For the latter intermediate, we did not 
observe the activity of dedicated dioxygenase. The low activity of 1,2-hydroxyquinol dioxygenase 
was observed for cells from the mono-substrate culture. Interestingly, the activity was lower than 
this observed for the control cells. Intermediates analysis revealed the presence of phthalic acid 
which may be further degraded into 4,5-dihydroxyphthalate, which was suggested to be formed by 
dioxygenation of phthalate to 4,5-dihydro-4,5-dihydroxyphthalate followed by decarboxylation to key 
metabolite—protocatechuate. This key metabolite may be cleaved by protocatechuate dioxygenases or 
converted to catechol [42,43]. Our results showed inhibition of protocatechuate 3,4-dioxygenase byDCF 
and lack of protocatechuate 4,5-dioxygenase activity. The lack of the activity of catechol 2,3-dioxygenase 
in DCF-treated cells and simultaneous high activity of catechol 1,2-dioxygenase indicated that the 
by-products are ortho cleaved to cis,cis-muconic acid. The formation of by-products without the 
aromatic structure allows to their further incorporation into the Kreb's cycle. Moreover, the activity of 
homogentisate 1,2-dioxygenase in the presence of DCF was observed. It is possible that one of DCF 
intermediates is homogentisate. This intermediate may be formed by hydrolysis of the amino bond 
and hydroxylation of DCF ring A. The activity of homogentisate 1,2-dioxygenase may indicate the 
formation of homogentisic (2,5-dihydroxyphenylacetic) acid also found by Ivshina et al. [2] during DCF 
degradation by R. ruber IEGM 346 strain. For this strain, homogentisic acid was further transformed 
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into 2-(p-benzoquinone-2)acetic acid. The presence of gene encoding quercetin 2,3-dioxygenase in the 
genome of Raoultella sp. KDF8 strain was confirmed by Palyzova et al. [20]. Herein, we confirmed 
the low activity of this enzyme in DCF-treated cells in the mono-substrate culture. This enzyme 
is known to catalyze the oxidative decomposition of quercetin to 2-protocatechuoylphloroglucinol 
carboxylic acid and carbon monoxide [44]. 2-protocatechuoylphloroglucinol carboxylic acid may be 
further transformed to 2,4,6-trihydroxycarboxylic acid, e.g., benzoic acid. The contribution of quercetin 
2,3-dioxygenase as well as salicylate 1,2-dioxygenase in DCF degradation by strain KB4 is unclear. 
The proteomic analysis performed by Palyzova et al. [20] revealed the engagement of proteins assigned 
to benzoate degradation cluster into DCFdegradation. Our study confirmed the activity of both enzyme 
and gene encoding benzoate 1,2-dioxygenase during DCF degradation by the KB4 strain. Benzoate 
1,2-dioxygenase catalyzes cleavage of benzoate to 1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate, 
which may be further transformed to catechol. Very low activity of hydroquinone 1,2-dioxygenase, 
peroxidase and laccase indicate that those enzymes are not significantly involved in the bacterial DCF 
degradation. Measurement of ammonia concentration indicates deaminase activity, which is also 
confirmed by the results of deaminase gene expression analysis. Worth to note is the significantly 
higher ammonia concentration detected for mono-substrate culture, compared to co-metabolic and 
control with Glc. Moreover, appearance of a monocyclic intermediate of DCF also confirms the role of 
the amino acid hydrolyzing enzyme in DCF degradation.
The surface charge of bacteria at neutral pH is negative mainly due to the complex structure of 
the cell wall that contains anionic surface groups [45]. The exposure of the KB4 cells on the increasing 
DCF concentrations resulted in the significant (p < 0.01) changes in the electro-surface properties 
measured by zeta-potential in the control and DCF-treated cells. A gradual decrease in zeta-potential 
was observed at the examined DCF concentration ranged from 0 to 3 mg L-1. A similar trend was 
observed by Ivshina et al. [2] who exposed cells of R. ruber IEGM 346 on high (50 mg L-1) and 
environmentally relevant concentrations (50 pg L-1) of DCF. Despite that, at the first stage of the 
experiment, the shift of zeta-potential value was observed, which was attributed to the cationic nature 
of DCF sodium salt and its interplay with mycolic acid -COOH groups present in the rhodococcal cell 
wall [2]. In our study, the shift towards the positive value was not observed. Probably, the negatively 
charged phthalate ion formed during degradation outweighs the balance between the negatively 
charged components of the bacterial cell membrane and the cationic nature of DCF sodium. This leads 
to a significant increase in negative charge at the interface. Despite that, during bacteria cultivation, 
the pH of the culture is subject to change and the number of the involutional and lysed cells increased 
which is also reflected in the general cell's potential. For the same range of DCF concentration as for 
zeta-potential measurements, the cell wall hydrophobicity estimation was performed. The cells of 
the KB4 strain unexposed to ecopollutants cultivated in the minimal medium were characterized by 
low hydrophobicity measured by the microbial adhesion to hydrocarbons (MATH) test [32]. Similarly 
to the study performed on rhodococci [2], the cell wall of the KB4 after DCF exposure became 
more hydrophobic. The interaction between DCF molecules with the cells' compounds boosted cell 
aggregation mainly through the elevated hydrophobicity. The decrease of zeta-potential and shift of 
the cell wall to being more hydrophobic was also observed by Yalęin et al. [46] for P. putida exposed 
on polycationic cetyltrimethylammonium bromide surfactant and Mohanty and Mukherji [47] for 
Triton X-100 treated Burkholderia sp. strain. Both compounds possess a cationic character similar to 
DCF sodium molecule. Moreover, all these compounds are characterized by a hydrophobic nature. 
On the other hand, no simple correlation between alteration in zeta-potential and hydrophobicity 
was observed by Smułek et al. [48] for Rahnella sp. EK12 strain after long-term contact with saponins 
and rhamnolipids.
The presence of xenobiotics in the environment may result in severe changes in the liquidity 
and integrity of the cell membrane [49,50]. From the environmental point of view and the potential 
usage of the KB4 strain in bioremediation processes, the lack of significant alterations at as high 
as 1 mg L-1 of DCF concentration in the lipid composition is beneficial. However, for all tested 
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time points, a significant increase in the cyclopropane and branched fatty acids (without 18 h) was 
observed. The properties of the membrane depend on the ratio of the straight-chain and branched 
fatty acids as well as the saturated and unsaturated one [51]. The negative influence of aromatic 
pharmaceuticals on the example of ibuprofen on bacterial membrane properties was shown by 
Marchlewicz et al. [50]. In the presence of ibuprofen at the concentration of 2.0 g L-1 , high content of 
branched fatty acids, mainly 18:0 anteiso, and a low amount of unsaturated fatty acids were identified. 
Herein, after DCF exposure, we observed the same trend, but a crucial branched fatty acid with 
the highest content after 24 h of incubation was identified as 19:0 anteiso. The increased content of 
branched fatty acids with a simultaneous high content of long-chain fatty acids modulates membranes' 
fluidity through the increase of the temperature phase transition, which results in the decrease of 
membrane permeability [50,52]. A similar tendency regarding the elevated content of the branched 
fatty acids was reported by Unell et al. [53] for Arthrobacter chlorophenolicus A6 strain grown on 
phenol and its chloro- and nitro- derivatives. Górny et al. [54] investigated the impact of naproxen 
(other polycyclic NSAIDs) on the fatty acids composition on the example of Gram-positive Bacillus 
thuringiensis B1(2015b) strain. The presence of naproxen at a concentration as high as 4.8-5.2 g L-1 
causes severe alterations in the membrane composition, i.e., the presence of the 16:0 iso 3OH acid 
only in the samples cultivated with naproxen, the slight decrease in the content of 18:0 anteiso acid at 
the highest tested concentration and remarkable decrease of the 18:1 m9c acid. Palyzova et al. [55] 
described the alterations of lipid profile after DCF exposure in the time ranging from 24 to 72 h at 
a concentration of 1.0 g L-1 observed for Raoultella sp. KDF8 strain. The most significant changes 
concerned shifting from the mono-unsaturated to cyclopropane fatty acids, particularly 16:1 against 
17:0 cyclo, which resulted in the geometric rearrangement of membranes. Authors hypothesized that 
due to those changes, strain is able to deal with destabilization of the inner and outer membrane. 
Moreover, decreased amounts of phosphatidylethanolamine with prolonged incubation time, and 
increased amounts of phospholipids having three or four acyls i.e., acyl-phosphatidylglycerol and 
cardiolipin with the prolonged time of cultivation, were observed [15,51,55].
Intracellular redox status of the bacterial cell can be altered by different environmental stimuli 
leading to the oxidative stress and subsequently, cell death [56]. The level of oxidative stress can be 
evaluated by various systems based on the measurable biochemical, morphological or physiological 
alterations caused by the toxic agents. In this study, the cells injury and oxidative stress triggered by 
DCF treatment were estimated by analysis of SOD and CAT activities, by measuring the concentration 
of LPX as well as by the activity of alkaline and acid phosphatases, which are responsible for the 
dephosphorylating reactions [28]. High values of SOD activity obtained in mono-substrate culture 
with DCF correlated with MDA concentrations clearly indicate oxidative stress caused by the presence 
of DCF. In the presence of Glc, with much more intense cell metabolism, probably DCF and its toxic 
metabolism products are rendered harmless much faster. On the other hand, low CAT activities 
values are surprising, both in mono-substrate and co-metabolic culture. Similar effect was observed by 
Zhang et al. [57] during a study on the response of antioxidant enzymes in E. coli K12 and B. subtilis B19 
to atrazine stress. Results obtained for alkaline phosphate activity showed that the comparable level 
was observed for both, mono-substrate and co-metabolic cultures. Since the activity of phosphatases 
is strictly dependent on the pH of the cultures, its increased activity observed in mono-substrate 
conditions is consistent with the slightly basic pH observed during mono-substrate degradation. 
The high activity observed in the co-metabolic culture with the slightly acidic pH was less expected. 
For the control with Glc, the significantly lower activity indicated that the observed activity for the rest 
systems was induced by DCF presence. Acid phosphate with the pH optimum ranging from 3.5-7.0 [58] 
showed low activity for all tested conditions with the highest drop observed for mono-substrate culture 
characterized by the most alkaline pH. The elevated activity of alkaline phosphate after DCF treatment 
was reported by Chouchan and Sharma [59] in serum and skeletal muscle in mice. The sub-chronic 
exposure in the last two stages of treatment was presumably attributed to the detrimental effect of 
DCF on tissues, mainly by the affecting of transmembrane permeability of DCF, especially considering 
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the involvement of the enzyme into adsorption and transport across the membranes. The alkaline 
phosphate mode of action was also connected to replacing by DCF the zinc atom in the active site 
of the enzyme. The accumulation of LPX measured by MDA concentration after DCF exposure 
coupled with the intensified oxidative stress met the criteria assumed by Bagnyukova et al. [60], 
who postulated that the formation of LPX is strictly involved in the intensification of enzymes which 
activity is characterized for oxidative stress, i.e., CAT. The correlation between the formation of LPX 
and CAT activity was shown by Saucedo-Vence et al. [61], who proved the simultaneous increase in 
the CAT activity and the concentration of LPX in common carp exposed to DCF at the concentration of 
7 mg L-1. On the contrary, Gómez-Olivan [62], who studied the oxidative stress in the presence of DCF 
in Daphnia magna at the concentration of 1 g L-1, showed exceeding 90% increase in lipid peroxidation 
compared to control values, but CAT activity remained unchanged. Quite low concentrations of MDA 
formed for all examined treatments could indicate the low involvement of cytochrome P-450 in the 
biotransformation of DCF by the KB4 strain. However, despite the low concentration of MDA in the 
co-metabolic culture, the cytochrome P-450 gene expression was up-regulated. On the other hand, 
down-regulation observed in the mono-substrate culture was not reflected in the MDA concentration. 
For eukaryotes, the formation of the highly unbalanced oxygenated by-product the oxy-cytochrome 
P-450 complex has been observed, which may induce lipid peroxidation by releasing the superoxide 
anion[27,63]. Moreover, Feito et al.[64] observed the hormesis after 90min ofDCF exposure manifested 
by the decrease in LPX in Danio rerio embryos. At the higher concentration than 0.03 |u.g L-1 of DCF, 
LPX increased reaching the so-called zone of compensation. Hypothetically, under these conditions, 
the hormetic stimulus fails to compensate for the damage reduction and subsequently, the divergences 
between biomarker levels in the examined samples and controls are indeterminate.
4. Materials and Methods
4.1. Bacterial Strain
The object of this study was P. moorei KB4 isolated from the activated sludge previously described 
as paracetamol-degrading strain [33,65].
4.2. Degradation Experiments
Degradation experiments were performed at 30 ◦C in mineral salts medium (MSM) with the 
following composition: g L-1: 3.78 Na2HPO4 x 12 H2O; 0.5 KH2PO4; 5.0 NH4Q; 0.2 MgSO4 X 7 H2O 
and 0.01 yeast extract under (1) mono-substrate conditions with 1 mg L-1 of DCF and initial OD600 set 
at 0.750, (2) co-metabolic conditions with glucose at a concentration of 0.1% (v/v), 1 mg L-1 of DCF 
and initial OD600 set at 0.05, (3) co-metabolic conditions with glucose (0.1%, v/v) and sodium acetate 
at the concentration of 5.6 mM, 1 mg L-1 of DCF and initial OD600 set at 0.05. The degradation rate 
was determined with the High-Performance Liquid Chromatography (HPLC) technique using Merck 
Hitachi reversed-phase chromatograph (Mannheim, Germany), equipped with a column Ascentis 
Express® C18, pre-column Opti-Solv® EXP and UV/Vis DAD detector. The mobile phase consisted 
of acetonitrile, methanol and 1% acetic acid (50:30:20, v/v, flow-rate 1 mL min-1). The detection 
wavelength was set at 276 nm. DCF in the supernatant was identified by comparing the HPLC retention 
time and UV spectra with that of the external standard [23].
4.3. Secondary Metabolites Identification
Identification of the secondary metabolites formed during DCF degradation in each treatment 
was performed using liquid chromatography in reverse phase system coupled with a mass detector 
(UHPLC/MS/MS) Shimadzu LC/MS-8040, using a Luna Omega C18 1.6 |4m column (100 X 2.1 mm, 
Phenomenex, (Torrance, CA, USA) and mobile phase consisted of: A—5 mM aqueous solution of 
ammonium acetate, pH5.8, B—acetonitrile. The mobile phase flow was 0.4 mL min-1 and the oven 
temperature was 30 °C. The elution program was as follows: 0-2 min—10% isocratic B, 2-9 min from 
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10 to 70% B, 9-10 min—isocratic 70% B, 10-10.5 min—from 70 to 5% B, 10.5-14 min—isocratic 5% 
B. Mass spectrometer parameters were: nebulizing gas flow 3 L min-1, drying gas flow 8 L min-1, 
temperature 250 ◦ C desolvation line, 400 ◦ C heating block temperature. The analyses were performed 
in multiple reaction monitoring (MRM)mode [23]. For gas chromatography the samples were prepared 
according to Marchlewicz et al. (2017). Prior to analysis, to each sample 0.1 mL of derivatization 
reagent MTBSTFA with 1% t-BDMCS was added. After incubation at 60 ◦ C for 30 min, the samples 
were dissolved in 1 mL of hexane. The qualitative analysis of metabolites was performed on PEGASUS 
4D GCxGC-TOFMS gas chromatograph (LECO Corp., St. Joseph, MI, USA) connected to a BPX5 
(5% phenyl equivalent, 28 m X 0.25 mm; 0.25 pm) capillary column (SGE Int., Melbourne, Australia). 
The ion source and transfer line temperature were set at 250 ◦C. Helium was used as carrier gas, with a 
flow of 1.0 mL min-1. After splitless injection of 1 pL of the sample, the oven temperature was set and 
maintained for 2 min at 40 ◦C, then it was applied a heating ramp to 300 ◦C at a rate of 12 ◦ C/min and 
the temperature of the oven was maintained for 15 min. The ionization source was operated in the 
positive ion mode (electron energy: 70 V) and the acquisition rate was set at 10 spectra/s [66].
4.4. Analysis of the Specific Activity of Selected Enzymes Involved in DCF Degradation
For enzymes activity assay culture of the KB4 strain exposed to 1.0 mg L-1 of DCF was harvested 
by centrifugation (5000X g, 4 ◦C, 20 min), the pellet was washed with 50 mM of phosphate buffer 
(pH 7.2) and re-suspended in the same buffer. Cell extract was prepared by sonication (6 times 
for 15 s, with 30 s breaks with frequency of 20 kHz) of the whole-cell suspension and centrifuged 
(10,000 X g, 4 ◦ C, 30 min). The obtained supernatant was used as a crude extract for further enzyme 
assays. Aromatic monooxygenase, catechol 1,2-dioxygenase, catechol 2,3-dioxygenase, protocatechuate 
3,4-dioxygenase, protocatechuate 4,5-dioxygenase, gentisate 1,2-dioxygenase, hydroxyquinol and 
hydroquinone 1,2-dioxygenase, laccases and peroxidases were assayed as was previously described by 
Marchlewicz et al. [66]. The activity of the dioxygenase catalyzed dihydroxylation was determined 
according to Wojcieszynska et al. [67]. The activity of salicylate 1,2-dioxygenase was measured according 
to Górny et al. [54]. Quercetin 2,3-dioxygenase was measured according to Schaab et al. [44], benzoate 
1,2-dioxygenase was measured according to Wolfe et al. [68]. Homogentisate 1,2-dioxygenase was 
determined according to Sariaslani et al. [69]. Deaminase was determined according to Żur et al. [65].
4.5. Analysis of Expression of Selected Genes Encoding Enzymes Involved in Microbial Degradation of DCF
For gene expression analysis total RNA was isolated from bacteria cultivated under mono- and 
co-metabolic conditions using a GeneMATRIX Universal RNA Purification Kit (EURx, Gdansk, Poland). 
The RNA concentration was quantified by measuring the absorbance at 260 nm using an ND-1000 
NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA, USA). The residual genomic DNA 
was digested using RNase-free DNase (Invitrogen Life Technologies, Carlsbad, CA, USA) and the 
purity of the RNA samples was assessed at the absorbance ratios of OD260/280 and OD260/230, while its 
structural integrity was determined using agarose gel electrophoresis. Single-stranded cDNA was 
synthesized from 1 pg of the total RNA using a RevertAid First Strand cDNA Synthesis Kit (Thermo 
Scientific, Waltham, MA, USA) according to the manufacturer's instructions. The generated cDNA 
was used for the RT-qPCR reactions using a LightCycler® 480 SYBR Green I Master (Roche, Basel, 
Switzerland)in a LightCycler® 480 Real-Time PCR System (Roche, Basel, Switzerland). All of the 
PCR reactions were performed in 96-wells Multiwell Plates under the following conditions: 10 min 
at 95 ◦C and 45 cycles of 15 s at 94 ◦C, 30 s at 60 ◦C and 30 s at 72 ◦ C. Three biological replicates and 
two technical replicates were used. The gene encoding gyrase (gyrA) was used as internal control [33]. 
The relative expression level was calculated according to Livak and Schmittgen [70]. Primers that were 
specific for the selected genes were designed using Geneious Prime (version 2019.0.3) and are listed in 
Table S2.
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4.6. Zeta Potential Measuring
The zeta potential was calculated from the Smoluchowski equation following measurements 
of electrophoresis mobility using the ZetaPlus instrument (Brookhaven Instruments Co., Holtsville, 
NY, USA). The changes in zeta potential were measured after the exposure of the cells at 1, 2 and 
3 mg L-1 of DCF. Bacterial cells from the exponential growth phase were centrifuged (8000x g, 5 min) 
and washed twice with MSM to remove residual of DCF and then suspended in the same medium to a 
final concentration of 108 CFU mL-1 [71,72].
4.7. Cell Wall Hydrophobicity Measurements
Cell wall hydrophobicity measurements were performed as described by Kos et al. [73] and 
Nachtigall et al. [74]. The adherence was calculated from the following equation, (1 - At )/A0 x 100, 
where At means the absorbance at time 15 min and A0 the absorbance at time 0.
4.8. Fatty Acid Extraction and Analysis
The fatty acid composition of KB4 strain was determined after 16 h, 18 h and 24 h of cultivation in 
lysogeny broth (LB) medium (control sample), and LB medium containing DCF at the concentration 
of 1 mg L-1. Briefly, bacteria were harvested by centrifugation (5000x g, 4 ◦C, 20 min) and the cell 
pellets were washed twice with 0.9% NaCl to remove the residue of the culture medium. The fatty 
acid isolation and identification were conducted by the MIDI-MIS method [51]. Three replicates of 
data obtained from each treatment were analyzed statistically by one-way ANOVA. The statistical 
significance (p < 0.05) of the differences was assessed by a post hoc comparison of the means using the 
least significant difference (LSD) test. The FAMEs profiles were also subjected to principal component 
analysis (PCA). All analyses were performed using the Statistica 13.0 PL software. To examine the 
changes in FAMEs profiles of bacteria dependent on DCF expose and prevent the alterations caused by 
fatty acids that were only detected occasionally, the analysis of the FAMEs included only fatty acids 
with a content of at least 1% in the FAMEs profile.
4.9. Membrane Permeability Analysis
Changes in membrane permeability were estimated by crystal violet (CV) assay according to 
Pacholak et al. [72]. Briefly, bacteria were harvested in the exponential phase, centrifuged (5000x g, 
20 min, 4 ◦C) and washed with MSM. Biomass was re-suspended in MSM to fit the optical density 
approximately 1.0. Next, 0.95 mL of obtained cell suspension was mixed with 50 |u.L of CV solution 
(0.1 mg mL-1). Samples were incubated at 30 ◦C for 10 min and centrifuged (13,400x g, 15 min). 
The optical density of the supernatant (Asample) was measured at a wavelength of 590 nm. The OD of 
the CV solution mixed with MSM at the same ratio (Aviolet ) was considered as 100%. The permeability 
expressed as the percentage of CV uptake was calculated according to the equation:




4.10. Cells Injury and Oxidative Stress Analysis
The activity of alkaline and acid phosphatase was determined by the formation of p-nitrophenol 
at 415 nm for both crude extracts (intracellular) and in the supernatant (extracellular). Catalase activity 
was estimated by measuring the decrease in absorbance at 240 nm with 54 mM H2O2. The activity 
of superoxide dismutase was measured using SOD Assay Kit No 19160-1KT-F (Merck, Darmstadt, 
Germany) according to the manufacturer's instructions. One unit (U) of the enzyme activity was defined 
as the amount of enzyme required to generate 1 ^mol of product per minute. Protein concentration 
in the crude extract was determined by the Bradford method [66]. The activity of alkaline and acid 
phosphatase was calculated in Bessey units, denoting the amount of mmol of p-nitrophenol released 
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by the enzyme in 1000 mL of the enzyme fraction during 1 h of incubation. To determine the lipids 
peroxidation to 1 mL of crude extract, 1 mL of trichloroacetic acid (15%, w/v in 0.25 M HCl) and 1 mL of 
thiobarbituric acid (0.37%, w/v, in 0.25 M HCl) were added. Afterward, the mixtures were incubated at 
100 °C for 10 min. Samples were left to cool down, centrifuged (5000X g, 4 °C, 20 min) and measured 
spectrophotometrically at 535 nm. Two control samples were prepared, one by adding 1 mL of water 
instead of crude extract, and the second by adding 1 mL of water instead of thiobarbituric acid [75]. 
The concentration of lipids peroxidation products was calculated based on the malonate aldehyde 
molecular extinction coefficient £ = 156,000/cm-1 M-1.
4.11. Statistical Analysis
All of the data were expressed as the mean value and standard deviation of three biological 
replicates. Data were analyzed using Microsoft Office Excel 2010 and Statistica® 13.0 PL (TIBCO 
Software Inc., Palo Alto, CA, USA). To test the normality of the data distribution the Shapiro-Wilk 
(p < 0.05) test was applied. The statistical significance (p < 0.05 or p < 0.01) of any differences were 
analyzed using one-way ANOVA and evaluated by a post-hoc test of the means using the lowest 
significant differences (LSD) test.
5. Conclusions
P. moorei KB4 was able to degrade 0.5 mg L-1 of DCF in mono-substrate and 1 mg L- 1 in co-metabolic 
culture with Glc and SA within 12 days. For all established cultures, two key DCF metabolites 
have been identified, i.e., 4'-OH-DCF and DCF-lactam. The specific activity of enzymes putatively 
involved in DCF bacterial degradation confirmed the multidirectional character of DCF metabolism, 
including the formation of hydroxylated derivatives and aliphatic by-products without aromatic 
structure. The up-regulation of selected genes encoding degradative enzymes, i.e., monooxygenase, 
dihydroxylating dioxygenases, cleavage dioxygenases or cytochrome P-450, in DCF-treated cells 
testified about their involvement in the metabolic pathway of DCF. The exposure of the KB4 cells on 
DCF caused a decrease in zeta-potential with a simultaneous increase in the cell wall hydrophobicity. 
These changes were also coupled with a rise in the membrane's permeability and alterations in the 
fatty acids' composition. The increase in the branched and cyclopropane fatty acids was connected 
with a reduced amount of unsaturated ones. The elevated activity of SOD and CAT indicated that DCF 
triggered oxidative stress.
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Abbreviations
DCF Diclofenac






ANOVA Analysis of variance
HPLC High-Performance Liquid Chromatography
UHPLC/MS/MS Ultra-High Performance Liquid Chromatography coupled with Mass Spectrometry
LB Lysogeny broth





DAD Diode array detector
LSD Least significant differences test
CFU Colony forming unit
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